168 related articles for article (PubMed ID: 28397455)
1. [Application of synthetic and semisynthetic polymers (Kollidon K30 and hydroxypropylmethylcellulose) as carriers of ketoprofen in solid oral prolonged-release dosage forms].
Linka W; Kot M; Kołodziejczyk M
Polim Med; 2016; 46(2):145-153. PubMed ID: 28397455
[TBL] [Abstract][Full Text] [Related]
2. [Applications of synthetic and semisynthetic polymers (Kollidon K25, Kollidon K90 and Hydroksyethylocellulose) as carriers of ketoprofen in solid oral prolonged release dosage forms. The impact of selected non-ionic surfactants (Tween 80 and Rofam 70) on the release kinetics].
Linka W; Kamińska M; Kołodziejczyk MK
Polim Med; 2019; 49(1):5-18. PubMed ID: 31464108
[TBL] [Abstract][Full Text] [Related]
3. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
[TBL] [Abstract][Full Text] [Related]
4. Study of controlled-release floating tablets of dipyridamole using the dry-coated method.
Chen K; Wen H; Yang F; Yu Y; Gai X; Wang H; Li P; Pan W; Yang X
Drug Dev Ind Pharm; 2018 Jan; 44(1):116-124. PubMed ID: 28956647
[TBL] [Abstract][Full Text] [Related]
5. [Modern polymers in matrix tablets technology].
Zimmer Ł; Kasperek R; Poleszak E
Polim Med; 2014; 44(3):189-96. PubMed ID: 25739125
[TBL] [Abstract][Full Text] [Related]
6. Subcoating with Kollidon VA 64 as water barrier in a new combined native dextran/HPMC-cetyl alcohol controlled release tablet.
Castellanos Gil E; Iraizoz Colarte A; Lara Sampedro JL; Bataille B
Eur J Pharm Biopharm; 2008 May; 69(1):303-11. PubMed ID: 18053697
[TBL] [Abstract][Full Text] [Related]
7. Effects of formulation and process variables on the release of a weakly basic drug from single unit extended release formulations.
Kranz H; Wagner T
Eur J Pharm Biopharm; 2006 Jan; 62(1):70-6. PubMed ID: 16154330
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Influence of Various Polymers on Dissolution and Phase Behavior of Carbamazepine-Succinic Acid Cocrystal in Matrix Tablets.
Ullah M; Ullah H; Murtaza G; Mahmood Q; Hussain I
Biomed Res Int; 2015; 2015():870656. PubMed ID: 26380301
[TBL] [Abstract][Full Text] [Related]
9. Formulation optimization, in vitro characterization and stability studies of sustain release tablets of Ketoprofen.
Hafeez A; Razvi N; Talib N; Ghayas S; Anjum F; Bushra R
Pak J Pharm Sci; 2019 May; 32(3 (Supplementary)):1245-1251. PubMed ID: 31303597
[TBL] [Abstract][Full Text] [Related]
10. Formulation and evaluation of controlled release matrices of ketoprofen and influence of different co-excipients on the release mechanism.
Wahab A; Khan GM; Akhlaq M; Khan NR; Hussain A; Khan MF; Khan H
Pharmazie; 2011 Sep; 66(9):677-83. PubMed ID: 22026123
[TBL] [Abstract][Full Text] [Related]
11. Development of theophylline sustained release dosage form based on Kollidon SR.
Reza MS; Quadir MA; Haider SS
Pak J Pharm Sci; 2002 Jan; 15(1):63-70. PubMed ID: 16414869
[TBL] [Abstract][Full Text] [Related]
12. The influence of polymer content on early gel-layer formation in HPMC matrices: The use of CLSM visualisation to identify the percolation threshold.
Mason LM; Campiñez MD; Pygall SR; Burley JC; Gupta P; Storey DE; Caraballo I; Melia CD
Eur J Pharm Biopharm; 2015 Aug; 94():485-92. PubMed ID: 26143369
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of injection moulding as a pharmaceutical technology to produce matrix tablets.
Quinten T; De Beer T; Vervaet C; Remon JP
Eur J Pharm Biopharm; 2009 Jan; 71(1):145-54. PubMed ID: 18511248
[TBL] [Abstract][Full Text] [Related]
14. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
[TBL] [Abstract][Full Text] [Related]
15. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
[TBL] [Abstract][Full Text] [Related]
16. Investigation of hypromellose particle size effects on drug release from sustained release hydrophilic matrix tablets.
Mitchell SA; Balwinski KM
Drug Dev Ind Pharm; 2007 Sep; 33(9):952-8. PubMed ID: 17891581
[TBL] [Abstract][Full Text] [Related]
17. STUDYING THE IMPACT OF FORMULATION AND PROCESSING PARAMETERS ON THE RELEASE CHARACTERISTICS FROM HYDROXYPROPYL METHYLCELLULOSE MATRIX TABLETS OF DICLOFENAC.
Elzayat EM; Abdel-Rahman AA; Ahmed SM; Alanazi FK; Habib WA; Sakr A
Acta Pol Pharm; 2016; 73(2):439-52. PubMed ID: 27180437
[TBL] [Abstract][Full Text] [Related]
18. Towards functional characterization of excipients for oral solid dosage forms using UV-vis imaging. Liberation, release and dissolution.
Li Z; Sun Y; Bar-Shalom D; Mu H; Larsen SW; Jensen H; Østergaard J
J Pharm Biomed Anal; 2021 Feb; 194():113789. PubMed ID: 33298380
[TBL] [Abstract][Full Text] [Related]
19. New Hydrophilic Matrix Tablets for the Controlled Released of Chlorzoxazone.
Creteanu A; Lisa G; Vasile C; Popescu MC; Pamfil D; Lungu CN; Panainte AD; Tantaru G
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791175
[TBL] [Abstract][Full Text] [Related]
20. Influence of water-soluble polymers on the in vitro performance of floating mucoadhesive tablets containing metformin.
Rajab M; Jouma M; Neubert RH; Dittgen M
Drug Dev Ind Pharm; 2014 Jul; 40(7):879-85. PubMed ID: 23607725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
